Skip to main content

Table 1 Dose parameters

From: The dose distribution in dominant intraprostatic tumour lesions defined by multiparametric MRI and PSMA PET/CT correlates with the outcome in patients treated with primary radiation therapy for prostate cancer

 

Median, Mean (range)

 

PG

SPG

DIL-imaging

p value (Friedman test)

Dmean, Gy

75.5, 75

(65.9–79.8)

75.5, 75

(66–79.8)

75.3, 75

(65.7–79.9)

p = 0.296

Dmin, Gy

72, 70.6

(49.7–77.7)

72, 70.7

(49.7–77.7)

73.2, 72.5

(53.7–78.3)

p < 0.001

Dmax, Gy

77.8, 77.7

(68.4–82.3)

77.7, 77.7

(68.4–82.3)

77, 76.7

(67.3–82)

p < 0.001

  1. Nonparametric Friedman test was used to evaluate the differences between the calculated dose-volume parameters. Post-hoc analyses using Wilcoxon matched-pairs signed rank test showed that the maximum dose was significantly lower in DIL-imaging compared to PG and SPG, whereas the minimum dose was significantly higher in DIL-imaging compared to PG and SPG (p < 0.05)
Back to article page

Radiation Oncology

ISSN: 1748-717X

Contact us